Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

1(20%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_3

40%

Ph not_applicable

60%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 3Large-scale testing

2(40.0%)

N/ANon-phased studies

3(60.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(3)

Terminated(1)

Detailed Status

Completed3

Withdrawn1

Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 3

Trials by Phase

Phase 32 (40.0%)

N/A3 (60.0%)

Trials by Status

completed360%

withdrawn120%

active_not_recruiting120%

Recent Activity

1 active trials

Showing 5 of 5

completednot_applicable

Clinical Trials (5)

Showing 5 of 5 trials

NCT07645183Not Applicable

Advanced Technology for Myopia Control in Children and Young Adults

Completed

NCT05331378Not Applicable

Clinical Evaluation of a Myopia Control Lens in Slowing Myopia Progression

Active Not Recruiting

NCT05527015Phase 3

Bifocal Spectacles vs. Single Vision Spectacles for Esotropia Greater at Near

Withdrawn

NCT03831919Not Applicable

Trial of Hoya SYNC III Design Lenses

Completed

NCT00000113Phase 3

Correction of Myopia Evaluation Trial (COMET)

Completed

All 5 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 5